Life sciences tax planning upheaval: How the OBBBA transforms your strategic approach
July 18, 2025
The recently enacted One Big Beautiful Bill Act (OBBBA), signed into law on July 4th, 2025, has fundamentally reshaped the tax landscape for pharmaceutical companies, biotech businesses, and medical device manufacturers.
Learn More